NASDAQ:RNA | Free Cash Flow | Atrium Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2025-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$31.14M$2.1M-$33.24M
2025-03-31-$11.1M$0.00-$11.1M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income